logo

Shariah compliance overview

Halal

Supernus Pharmaceuticals, Inc. (SUPN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for central nervous system (CNS) disorders within the United States.

Supernus Pharmaceuticals, Inc. (SUPN) operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 1.81% (limit 5%), interest-bearing debt is 18.63% (limit 30%) and interest-bearing securities and assets are 14.29% (limit 30%).

If you hold SUPN, give 1.81% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
1.81%Limit 5%Pass
Interest-bearing debt
18.63%Limit 30%Pass
Interest-bearing securities and assets
14.29%Limit 30%Pass
Dividend purification
1.81%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Supernus Pharmaceuticals, Inc. (SUPN). Current Akinda screening label: Halal.